Literature DB >> 1281780

Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues.

C Hoang-Vu1, H Dralle, G Scheumann, C Maenhaut, R Horn, A von zur Mühlen, G Brabant.   

Abstract

Steady state mRNA transcript levels of thyroid differentiation markers such as TSH receptor (TSHR), thyroglobulin (Tg) and thyroid peroxidase (TPO) as well as a potential marker of dedifferentiation, c-myc, marker were investigated in patients with thyroid tumors and in normal controls using Northern blot analysis. Blots were normalized by acridine orange staining whereas analysis of beta-actin mRNA levels revealed highly variable levels already in normal tissue suggesting regulation of this "constitutively" expressed gene. Determination of c-myc mRNA revealed increased steady state mRNA levels in anaplastic carcinomas (ATC) as compared to normal tissues. However, in some patients c-myc transcript levels were lower in the tumor than in the adjacent normal tissue reducing the significance of c-myc as a marker of dedifferentiation. High levels of TSH mRNA were found in control thyroids, whereas in ATC no normal TSHR mRNA was detected. In PTC and follicular thyroid carcinomas (FTC) the transcripts varied from increased to markedly reduced levels. In one patient with FTC 2 independent preparations of the tumor revealed different results, undetectable and clearly detectable TSHR mRNA levels. Xenotransplantation of this tissue on nude rats showed a variable expression pattern in the individual xenotransplantations suggesting heterogeneity of the tumor tissue. Tg and TPO mRNA were strongly expressed in normal tissues and completely lost in all ATC. In differentiated thyroid tumors the transcript levels of Tg and TPO varied from normal to complete loss of expression of either Tg or TPO, or both.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281780     DOI: 10.1055/s-0029-1211176

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  12 in total

1.  Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft.

Authors:  Manoj Garg; Ryoko Okamoto; Yasunobu Nagata; Deepika Kanojia; Subhashree Venkatesan; Anand M T; Glenn D Braunstein; Jonathan W Said; Ngan B Doan; Quoc Ho; Tadayuki Akagi; Sigal Gery; Li-Zhen Liu; Kar Tong Tan; Wee Joo Chng; Henry Yang; Seishi Ogawa; H Phillip Koeffler
Journal:  J Clin Endocrinol Metab       Date:  2014-11-03       Impact factor: 5.958

2.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles.

Authors:  Y Huang; M Prasad; W J Lemon; H Hampel; F A Wright; K Kornacker; V LiVolsi; W Frankel; R T Kloos; C Eng; N S Pellegata; A de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

3.  Genome-wide appraisal of thyroid cancer progression.

Authors:  Volkert B Wreesmann; Ronald A Ghossein; Snehal G Patel; Charles P Harris; Erik A Schnaser; Ashok R Shaha; R Michael Tuttle; Jatin P Shah; Pulivarthi H Rao; Bhuvanesh Singh
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

4.  Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors.

Authors:  Svetlana Savin; Dubravka Cvejic; Tijana Isic; Ivana Petrovic; Ivan Paunovic; Svetislav Tatic; Marija Havelka
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

5.  The H723R mutation in the PDS/SLC26A4 gene is associated with typical Pendred syndrome in Korean patients.

Authors:  Mi Ae Cho; Su Jin Jeong; Sang-Mi Eom; Hyun-Young Park; Hyun-Yung Park; Young Joo Lee; Se Eun Park; So Young Park; Yumie Rhee; Eun Seok Kang; Eun Soek Kang; Chul Woo Ahn; Bong Soo Cha; Eun Jig Lee; Kyung Rae Kim; Hyun Chul Lee; Sung-Kil Lim
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.633

Review 6.  Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies.

Authors:  Jena D French
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330

7.  Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.

Authors:  Séverine Trouttet-Masson; Samia Selmi-Ruby; Françoise Bernier-Valentin; Valérie Porra; Nicole Berger-Dutrieux; Myriam Decaussin; Jean-Louis Peix; Agnès Perrin; Claire Bournaud; Jacques Orgiazzi; Françoise Borson-Chazot; Brigitte Franc; Bernard Rousset
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

8.  Expression of pendrin in benign and malignant human thyroid tissues.

Authors:  J Skubis-Zegadło; A Nikodemska; E Przytuła; M Mikula; K Bardadin; J Ostrowski; B E Wenzel; B Czarnocka
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

9.  Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?

Authors:  B Czarnocka; D Pastuszko; M Janota-Bzowski; A P Weetman; P F Watson; E H Kemp; R S McIntosh; M S Asghar; B Jarzab; E Gubala; J Wloch; D Lange
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

Review 10.  Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it?

Authors:  F A Verburg; C J M Lips; E G W M Lentjes; J M H de Klerk
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.